August 5, 2026- CVS Health Corporation announced operating results for the three months ended June 30, 2026.
- Second quarter total revenues increased to $106.1 billion, up 7.3% year-over-year
- Second quarter GAAP diluted EPS of $2.31 and Adjusted EPS of $2.58
- Generated year-to-date cash flow from operations of $10.6 billion
- Raising full-year 2026 guidance:
- GAAP diluted EPS guidance range to $6.84 to $7.04 from $6.24 to $6.44
- Adjusted EPS guidance range to $7.90 to $8.10 from $7.30 to $7.50
- Cash flow from operations guidance to at least $11.5 billion from at least $9.5 billion